TNDM — TANDEM DIABETES CARE INC

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1438133 ·
Last close
$17.06
Market Cap
$1.19B
52W High
$29.65
52W Low
$12.26
ADV30
2,596,201
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 283,690,000 160,422,000 -2,369,000 -7,085,000 1,159,494,000 72,840,000 1,024,407,000
Jun 2026 254,560,000 144,780,000 -13,792,000 -21,168,000 1,154,202,000 62,818,000 1,023,814,000
Mar 2026 247,221,000 136,788,000 -17,434,000 -20,393,000 1,153,394,000 179,325,000 1,020,991,000
Dec 2025 290,383,000 167,460,000 8,294,000 -589,000 881,112,000 90,634,000 725,942,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-5,523,000
Investing CF
$-277,224,000
Financing CF
$277,349,000
CapEx
$-56,219,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.93
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,294,096,000
Inventory
$135,106,000
Receivables
$162,065,000
ST Investments
$393,178,000
EBIT TTM
$-54,638,000
Pretax Income TTM
$-60,996,000
Interest Exp TTM
$6,358,000
Analysts
21

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,075,853,952
EBITDA
$-7,319,000
Free Cash Flow
$-65,562,376
Enterprise Value
$1,473,674,880
Total Cash
$443,081,984
Total Debt
$736,542,976
Shares Out
69,793,846
Trailing EPS
$-0.70
Book Value
$1.94
ROE
-36.7%
ROA
-1.6%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,014,736,000 -167,306,000 -204,710,000 881,112,000 725,942,000 155,170,000 -9,721,000
Dec 2024 940,203,000 -99,127,000 -96,025,000 967,658,000 704,560,000 263,098,000 24,225,000
Dec 2023 747,718,000 -233,230,000 -222,611,000 952,658,000 639,026,000 313,632,000 -31,810,000
Dec 2022 801,217,000 -92,848,000 -94,594,000 1,052,785,000 612,838,000 439,947,000 50,464,000

TTM Snapshot

Revenues TTM
$1,041,417,000
NetIncome TTM
$-63,315,000
OpCashFlow TTM
—
Assets (Latest)
$1,154,202,000
Forward EPS
$0.17

Max Pain — expiry 2027-01-15

max pain strike: $21.00 · spot: $17.05 · call oi: 673 · put oi: 2,615
Expected Move to 2027-01-15: ±$6.30 (36.95%) — implied range $10.75 – $23.35 · ATM straddle on $17.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
DRTS Alpha Tau Medical Ltd. $1.12B $12.09 —
NVCR NovoCure Ltd $1.30B $11.14 —
IRMD IRADIMED CORP $1.07B $83.45 —
ATEC Alphatec Holdings, Inc. $1.06B $6.94 —
IART INTEGRA LIFESCIENCES HOLDINGS CORP $1.05B $13.55 —

News headlines (Yahoo Finance, 1h cache)

Tandem Diabetes shares climb 5% after Stifel upgrades stock to Buy
2026-11-18 14:56 · Yahoo
Insulet downgraded, Tandem Diabetes upgraded: Wall Street's top analyst calls
2026-11-18 14:35 · Yahoo
Tandem wins FDA clearance for tubeless automated insulin delivery system
2026-11-16 11:48 · Yahoo
Tandem Diabetes stock jumps 8% on FDA clearance for tubeless pump
2026-11-13 15:11 · Yahoo
Can Tandem Diabetes Care (TNDM) Stay Cheap After Its Recall?
2026-11-13 09:10 · Yahoo
Tandem Diabetes Care Receives Multiple Health Canada Approvals for t:slim X2 Insulin Pump
2026-11-12 13:30 · Yahoo
TNDM Q3 2026 deep dive: business model transition, product launches, and leadership change
2026-11-10 10:53 · Yahoo
Can Tandem Diabetes Care (TNDM) Justify Its Valuation As Q3 Earnings Beat And CEO Change Land?
2026-11-07 20:14 · Yahoo
What Tandem Diabetes Care (TNDM) Said on Its Q3 Earnings Call
2026-11-06 21:14 · Yahoo
Tandem Diabetes Care names next CEO
2026-11-06 15:36 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.